MENU
FHLC
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

FHLC stock forecast, quote, news & analysis

The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index... Show more

Category: #Health
A.I.Advisor
published price charts
FHLC
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for FHLC with price predictions
Oct 21, 2026

FHLC's Indicator enters downward trend

The Aroon Indicator for FHLC entered a downward trend on October 12, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 159 similar instances where the Aroon Indicator formed such a pattern. In 134 of the 159 cases the stock moved lower. This puts the odds of a downward move at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for FHLC moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 27 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FHLC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

FHLC broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on FHLC as a result. In 68 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

The Moving Average Convergence Divergence (MACD) for FHLC just turned positive on October 12, 2026. Looking at past instances where FHLC's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.

FHLC moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FHLC crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 83%.

Following a +4.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where FHLC advanced for three days, in 257 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index. The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.

Market Cap

The average market capitalization across the Fidelity MSCI Health Care Index ETF (FHLC) ETF is 23.26B. The market cap for tickers in the group ranges from 37.07M to 1.13T. LLY holds the highest valuation in this group at 1.13T. The lowest valued company is EYPT at 37.07M.

High and low price notable news

The average weekly price growth across all stocks in the Fidelity MSCI Health Care Index ETF (FHLC) ETF was 33%. For the same ETF, the average monthly price growth was 154%, and the average quarterly price growth was 396%. IRON experienced the highest price growth at 36%, while EYPT experienced the biggest fall at -86%.

Volume

The average weekly volume growth across all stocks in the Fidelity MSCI Health Care Index ETF (FHLC) ETF was -10%. For the same stocks of the ETF, the average monthly volume growth was 5% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 49
Price Growth Rating: 47
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: 20 (-100 ... +100)
FHLC's Indicator enters downward trend